AI assistant
Sending…
VOLITIONRX LTD — Director's Dealing 2022
Aug 16, 2022
34395_dirs_2022-08-16_103bb18b-edeb-4c99-939e-d6847a66fafc.zip
Director's Dealing
Open in viewerOpens in your device viewer
{# SEO P0-1: filing HTML is rendered server-side so Googlebot
sees the full text without executing JS or following an
iframe to a Disallow'd CDN path. The content has already
been sanitized through filings.seo.sanitize_filing_html. #}
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2022-08-15-05:00
Reporting Person: Henshall Mickie (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-08-15-05:00 | Common Stock | A | 15000 | — | Acquired | 15000 | Direct |
Footnotes
F1: Ms. Henshall received restricted stock units subject to a 2-year vesting schedule, vesting as to 7,500 units on each of 08/15/23 and 08/15/24, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.